JACFX
Price
$20.62
Change
+$0.05 (+0.24%)
Updated
Jun 22 closing price
Net Assets
1.3B
VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
Interact to see
Advertisement

JACFX vs VMGMX

JACFX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
VS
JACFX vs. VMGMX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JACFX is a Hold and VMGMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. JACFX (1.3B). VMGMX pays higher dividends than JACFX: VMGMX (0.62) vs JACFX (0.00). JACFX was incepted earlier than VMGMX: JACFX (21 years) vs VMGMX (15 years). JACFX (0.89) is less costly to investors than VMGMX (0.07). JACFX is a more actively managed with annual turnover of: 137.00 vs. VMGMX (17.00). JACFX has a lower initial minimum investment than VMGMX: JACFX (0) vs VMGMX (3000). VMGMX annual gain was more profitable for investors over the last year : 12.44 vs. JACFX (9.59). VMGMX return over 5 years is better than : 31.82 vs. JACFX (-26.56).
JACFXVMGMXJACFX / VMGMX
Total Expense Ratio0.810.071,157%
Annual Report Gross Expense Ratio0.890.071,271%
Fund Existence21 years15 years-
Gain YTD15.4329.694159%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.3B33.8B4%
Annual Yield % from dividends0.000.62-
Returns for 1 year9.5912.4477%
Returns for 3 years48.6355.1788%
Returns for 5 years-26.5631.82-83%
Returns for 10 years18.29212.409%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.47N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.11N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.25N/A
N/A
MFS Blended Research Value Equity R4